Charles Bonnet syndrome (organic visual hallucinations)
Charles Bonnet · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Charles Bonnet syndrome is the occurrence of complex visual hallucinations in people with significant visual impairment who have intact insight and no psychiatric or cognitive disorder. It is benign and under-recognised; the main value is reassurance and avoiding misdiagnosis as psychosis or delirium.
Red flags
- Loss of insight or auditory/other-modality hallucinations (suggests psychosis)
- Acute onset with confusion (delirium)
- Features of Lewy body dementia (fluctuation, parkinsonism)
- New focal neurology or seizure activity
- Significant distress or functional impairment
Assessment
Differential diagnosis
- Charles Bonnet syndrome (visual loss, preserved insight, no other psychopathology)
- Delirium with visual hallucinations (acute, altered consciousness)
- Dementia with Lewy bodies (recurrent visual hallucinations, parkinsonism, fluctuation)
- Psychosis (usually auditory, lacks insight, other features)
- Drug-induced or occipital lobe pathology (seizures, stroke, tumour)
Investigations
- Clinical history confirming visual impairment and preserved insight
- Cognitive screen to exclude dementia
- Review medications for hallucinogenic effects
- Consider neuroimaging if atypical, new focal signs or seizure features
- Ophthalmology assessment of the underlying eye disease
Management
- Elicit the nature of the hallucinations (complex, formed images; patient knows they are not real)
- Confirm significant visual impairment and the absence of other psychopathology
- Exclude delirium, dementia with Lewy bodies and psychosis
- Consider occipital pathology if atypical (new focal signs, seizure features)
- Reassure the patient that this is a recognised, benign consequence of visual loss
- Optimise vision (treat eye disease, improve lighting, low-vision aids)
- Avoid antipsychotics as first line (limited benefit, side-effects)
- Refer to ophthalmology and provide information/support resources
Drugs & doses
No routine pharmacotherapy — reassurance and optimising vision are first-line
Treat any contributing eye disease via ophthalmology
Review and reduce any hallucinogenic/anticholinergic medications
Antipsychotics only in severe distressing cases, cautiously and specialist-led
Disposition
Reassure and discharge with ophthalmology follow-up for the underlying visual impairment; refer to psychiatry/old-age services only if diagnosis is uncertain or distress is severe.
Complications & pitfalls
- Misdiagnosis as psychosis leading to inappropriate antipsychotics
- Patient anxiety from fear of 'going mad'
- Masking of an evolving neurodegenerative disorder
- Social withdrawal
- Falls related to visual impairment
Exam pearls
- Preserved insight and visual impairment with no other psychopathology are the hallmarks
- Reassurance is the main treatment — patients are often relieved to learn it is benign and named
- Visual (not auditory) hallucinations with insight distinguish it from psychosis
- Consider dementia with Lewy bodies if hallucinations are accompanied by fluctuation and parkinsonism
- Optimising lighting and treating the eye disease can reduce symptoms
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.